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Chasing Molecules That Were Never There: Misassigned
Natural Products and the Role of Chemical Synthesis in
Modern Structure Elucidation




azaspiracid-1 · diazonamide A ·
natural products · revised structures ·
total synthesis
K. C. Nicolaou and S. A. SnyderReviews

















































































































































































































































































































































































































Themed issue: Natural Product Synthesis
HIGHLIGHT
Phil S. Baran et al.
Natural product synthesis in the age of scalability
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The inexorable force of chemical syn-
thesis to create matter with entirely new
properties has profoundly changed the
world—and arguably so—largely for the
better. Developed societies embrace the
service that chemistry can provide, while
otherwise cultivating a certain chemo-
phobia (certainly in Europe). Many
reasons are to be blamed for this some-
what schizophrenic attitude, including
some severe mistakes on our own side.
Another issue is the difficulty of convey-
ing the beauty of our science to the
general public. Organic chemistry uses
a notation that only an adept scholar is
able to understand. Mathematics and
music face a similar challenge: as a re-
sult, the fruits of these disciplines are
subject to mass consumption too, but
real appreciation is scarce and, maybe,
even declining as a consequence of
changing priorities in the education
system. One may complain about this
situation, but we are well advised to
keep touch with a broad audience.
Neither ignorance nor skepticism form
a sound basis for sustained public sup-
port for science in general and chemistry
in particular. In fact, dwindling financial
resources are an increasingly serious
menace for basic research in many
countries.
In times when money is tight, topics that
do not promise any short-term revenues
often have a hard time to get funded.
The political expectations often take the
form of top-down agendas that prede-
termine what scientists have to be inter-
ested in if they want to survive within
their system. Neither can I convince
myself that such “five-year plans” are
the best response to the challenges that
modern society is facing, nor do I
believe that they correspond particular-
ly well to the very nature of the chemical
sciences. Let me give you a few exam-
ples that I consider reasonably repre-
sentative.
It is fair to say that the organometallic
chemistry of palladium, an exceedingly
rare and expensive metal, has had
a tremendous impact on our quality of
life. Not only a panoply of important
drugs, but also agrochemicals, liquid
crystals, and even sun protecting agents,
are made through palladium catalysis,
with massive annual sales. Interestingly,
this success story can be traced back to
some pretty basic and curiosity-driven
investigations. One of the key contribu-
tions was made by Tsuji and coworkers,
who reacted malonate anions with stoi-
chiometric (!) amounts of allylpalladi-
um complexes to form mixtures (!) of
products that can be made much more
readily otherwise. Although definitely
not practical, this result has fundamen-
tally changed our understanding of or-
ganometallic chemistry because it
proved that organopalladium species
are electrophiles rather than nucleo-
philes (as essentially all other organo-
metallic species known at the time). In
similarly pioneering studies, Heck in-
vestigated the reactivity of organomer-
cury (!) compounds in the presence of
palladium salts. Incidentally, the author
was working in industry at the time.
Would any of these research projects get
funded under today!s circumstances? In
a climate favoring investigations of
practical relevance, such proposals
might well cause Homeric laughter.
Hence, everybody who has to take a drug
compound made by cross-coupling part-
ly owes his or her health the liberty of
the funding agencies forty years ago—
not to speak of the wealth that this
chemistry has ultimately created in
return to the start-up investment of
money. “This was sometime a paradox,
but now the time gives it proof” (Ham-
let).
In this context, I also kindly ask you to
re-read the original publication on biar-
yl formation through what later became
famous as the Suzuki coupling. Would
you have predicted then that this paper
will change the world and finally lead its
author to Stockholm? Olefin metathesis
is yet another formidable case; only
after a “lag period” of about three
decades of pretty basic organometallic
research was the avalanche set off.
Finally, I can!t help but reiterate the
story of Karl Ziegler, former director of
my own institute. As a young man he
discovered that benzylpotassium re-
agents add to stilbene. This somewhat
exotic result, however, actually denotes
the first recorded case of a carbometala-
tion reaction and, as such, Ziegler!s first
step on his path to polyethylene which
took no less than three more decades
from there on.
Of course, I appreciate that only very
few innovations gain such relevance. At
the meta-level however, these examples
showcase that innovation eventually
wins over trendiness, quality over polit-
ical agendas, originality over mass pro-
duction, curiosity over determinism,
reliability over mannerism. Whereas
glamour asks for immediate reward,
innovation means sustained success.
If you ever tried to chase a complex
natural product yourself, you may have
experienced how challenging, labor in-
tense, expensive, and even frustrating
[*] Prof. A. F!rstner
Max-Planck-Institut f!r Kohlenforschung













Natural Product Total Synthesis: As Exciting as Ever and Here To Stay
We have travelled far since 1828 and the interest attached to
'total synthesis' has disappeared
Sir Robert Robinson (1936)
The total synthesis of complex natural products still remains
among the most exciting and dynamic areas of research, with
representative publications in this area routinely ranking among
the most-read in every chemistry-focused journal. Three
excellent prior summaries of fantastic accomplishments in this
area have appeared in 2008,1 2013,2 and 2014,3 with the creation
of virtual issues highlighting many representative publications
from those time periods. In all of the editorials accompanying
those expertly curated virtual issues, strong cases were made for
why total synthesis continues to be an important and topical area
of investigation. In this editorial I’d like to address recent topical
issues surrounding the future of this field.4
Total synthesis and synthetic organic chemistry as a whole
provide society a fantastic return on investment with innumer-
able fundamental and applied tangible advancements. Historically,
chemists educated in this area are some of the most sought after
in industry, as the skills of making molecules can be utilized for
designing an infinite array of translational applications in medi-
cines, agrochemicals, and materials. But the justification for why
this pursuit endures goes beyond the simple argument of supply-
ing the demands of a particular labor market.5 From a fundamen-
tal perspective, total synthesis is a barometer and proving ground
for new methodologies and new strategies or ways of thinking.6
Lessons from such endeavors can illuminate unique or under-
appreciated areas of chemical reactivity. Powerfully simplifying
disconnections in the context of an obscure natural product family
can have enormous downstream impacts as well. From an applied
standpoint, having sustainable and reliable access to biologically
active natural isolates can demystify new areas of biology or pro-
vide promising candidates for drug discovery.7 In many cases
such pursuits can serve as the only means for structural identi-
fication.8 It is therefore puzzling that so frequently this area of
inquiry is criticized or its motives questioned.9 To be sure, the
study of total synthesis does not consume inordinate taxpayer
resources relative to other areas (quite the opposite, actually),10
and among journal readership such studies are of extreme interest
to the broad audience based on sheer download statistics. I would
argue that based on this statistic alone it is self-evident that
the field remains vibrant rather than stale and of little general
appeal.
Among outsiders or those disconnected from the intricacies of
the field, somemay view total synthesis or synthetic organic chem-
istry as a whole as being a “mature” field,11 perhaps even being
immediately amenable to automation12 or replacement with arti-
ficial intelligence algorithms.13 In my view, those efforts are cer-
tainly worthwhile as long as they don’t come at the expense of the
very field they wish to simplify. In other words, such efforts do
not intimidate, threaten, or provoke fear in the hearts of any
practitioner of synthesis. Promises of computational chemistry
and combinatorial chemistry displacing the field were made over
the years, yet we are still here.14 Thus, I would predict that our
species will become capable of interplanetary colonization long
before rooms of machines dramatically reduce the number of
employable synthetic chemists or eliminate them all together.12f
The perception of synthesis “maturity” is probably due to the field
being misunderstood rather than mature. This misunderstanding is
partially self-inflicted, as with every large accomplishment in the
area one can get the sense that an endpoint has been reached.15
As a community, we have become quite adept at being able to
make anything with enough resources, but we are still decades or
perhaps even centuries away frommaking everything well.16 The
“age of feasibility” 17 did a great job to advertise the former capa-
bility and perhaps deemphasize the latter deficiency, thus setting
the stage for critics to emerge.
The goals of sustainability and environmentally conscious
science underlie the precepts of modern chemistry, and natural
product synthesis is no different in that regard. Thus, the field
is moving toward simplifying the way molecules can be made18
so that perhaps one day even the most complex structures
can be obtainable by engineers rather than basic scientists.
It’s not visionary to speculate that computer-designed, fully
automated sequences are on the waythat is blatantly obvious.
Despite hubristic promises otherwise, that day is still far away.
Active practitioners in this area are fully cognizant of this fact but
either are too busy doing science to write countless essays, blog
posts, and opinion pieces on the subject or simply don’t have
a platform to do so. Well-designed retrosyntheses can fail even
in simple settings, reproducibility is still an issue with precise
experimental technique often essential for success,19 selectivity
(chemo, regio, stereo) is frequently hard to predict in com-
plex settings, serendipity still abounds, visceral creativity and
persistence determine success, and some of the most powerful
disconnections and new reagents need to be invented from
scratchthese facts bear repeating, especially to government
officials that fund science and the Editors that publish it.20 These
very same bleak facts also underlie the charm and appeal of the
area and are the reason that students are still magnetically
attracted to it. Indeed, total synthesis programs still evoke an
exciting sense of wonder and exploration of the unknown, not to
mention the artistic aspects and inherent beauty of the final route.
Thus, to state the obvious (to some), the “industry” of synthesis
cannot be heroically “disrupted” with engineering advances and
promises of utopian automation.21 That’s not to say that certain
aspects of synthesis can’t be made easier or accelerated with such
advances.22 And that’s also not to say that folks like me in the syn-
thesis community would not welcome such a day. Rather, it is still
boring old human ingenuity, creativity, and curiosity23 manifest-
ing through the invention of new enabling methods, catalysts,
reagents, and daringly different strategies that will push the field
forward with the most “disruptive potential”. In fact, many
industries (such as drug discovery and development) are moving
toward more and more complex targets,24 and it is widely recog-
nized that synthesis is often a rate-limiting step. For the reasons
articulated above, advances in total synthesis and methodology
can have a positive impact in making simple what was once
Published: April 11, 2018
Editorial
pubs.acs.org/JACSCite This: J. Am. Chem. Soc. 2018, 140, 4751−4755
© 2018 American Chemical Society 4751 DOI: 10.1021/jacs.8b02266































































































J A Y  D .  K E A S L I N G
Synthetic biology is essentially the assembly of well-characterized biological compo-
nents into a system that performs a function, 
such as synthesizing a chemical. The field has 
advanced to the point that one can imagine 
producing nearly any organic molecule — 
even those that are not produced naturally 
— in an engineered microorganism. This has 
enormous implications for the production of 
speciality and bulk chemicals, drugs and fuels. 
Structurally complex pharmaceutical ingre-
dients based on natural products are particu-
larly good targets for microbial production 
(Fig. 1a), because they can be difficult to pro-
duce by conventional chemical synthesis. Even 
when chemical syntheses for natural products 
are available, the routes used are often too long 
and/or low-yielding for large-scale prepara-
tion. For commercial production, such mole-
cules are therefore typically harvested from 
organisms that produce them naturally, or 
from a mutant that generates higher yields. 
Alternatively, a semi-synthesis can be used 
in which a precursor to a desired compound 
is obtained from an organism and then con-
verted to the final product using organic 
synthesis. However, these approaches tend to 
be time-consuming and expensive.
Naturally occurring compounds can be 
produced in microorganisms by transferring 
product-specific enzymes, or even whole 
metabolic pathways, from rare and/or geneti-
cally intractable organisms to those that can 
be readily engineered1. Similarly, fuels, bulk 
chemicals and speciality chemicals that are not 
produced naturally can be obtained by com-
bining enzymes or metabolic pathways from 
different hosts into a single microorganism, or 
by engineering enzyme functions2.
Synthetic biology has also been used for the 
large-scale semi-synthesis of natural products. 
For example, the antimalarial drug artemisinin 
is extracted from the plant Artemisia annua, 
but it is in short supply and is too expensive 
for most people with malaria3. By combining 
genes from A. annua and other organisms 
into a single strain of the yeast Saccharomyces 
cerevisiae, we have produced a fermentation 
process4 to make artemisinic acid — which 
can easily be converted to artemisinin using 
chemical methods5 — from simple sugars. 
The process is cost-effective, environmentally 
friendly and reliable, and is being developed 
for commercial production of the drug.
Synthetic biology has many advantages over 
chemical synthesis. First, the intermediates 
in a biosynthesis do not need to be purified 
before being used as substrates in the next 
reaction. Second, the many ‘protection’ and 
‘de-protection’ steps typical of chemical syn-
thesis — steps in which chemical groups are 
temporarily modified to stop them taking 
part in unwanted side reactions — can be 
avoided, because biosynthetic enzymes cata-
lyse reactions only at the required positions 
in a substrate, avoiding side reactions at other 
groups. Third, most products of enzymatic 
reactions are racemically pure (the products 
form as just one of two possible mirror-image 
isomers), which is important for biologically 
active molecules. Fourth, cells can be engi-
neered to secrete the final product, making it 
easier to purify. Finally, synthetic biology can 
use simple starting materials from renewable 
sources, helping to reduce our dependence on 
oil-derived feedstocks.
Even so, if synthetic biology is to match the 
power of synthetic chemistry, several problems 
must be addressed. For example, the biosyn-
thetic enzymes responsible for producing 
important natural products need to be iden-
tified, so that they can be used in syntheses. 
We must also improve our ability to design 
enzymes that catalyse reactions not found in 
nature6 if we are to expand the types of chem-
istry that can be engineered into cells. And we 
must learn how to reliably engineer biosyn-
thetic pathways to achieve desired outcomes.
I envisage a day when customized cells will 
be built as catalysts for the biosynthesis of 
natural products, by designing chromosomes 
that harbour genes encoding the necessary 
biosynthetic pathways and also the minimal set 
of genes needed to construct the host organ-
ism from minimal nutrients. That day is fast 
approaching.
Jay D. Keasling is in the Department of 
Chemical and Biomolecular Engineering, and 
the Department of Bioengineering, University 
of California, Berkeley, Berkeley, California 
94720, USA. He is also at the Lawrence 
Berkeley National Laboratory and at the Joint 




Synthetic chemistry has long been used to prepare useful compounds — especially those that are hard to obtain from 
natural sources. But synthetic biology is coming of age as an alternative strategy. A biologist and two chemists debate the 
merits of their fields’ synthetic prowess.
a b
Figure 1 | Reaction vessels. a, Some biologists have argued that structurally complex molecules are best 
prepared in genetically engineered organisms, such as the bacterium Escherichia coli (pictured). b, Others 
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